YM

Yuzuru Matsuda

KC Kyowa Hakko Kogyo Co.: 16 patents #48 of 943Top 6%
CE Cephalon: 5 patents #60 of 277Top 25%
OG Osaka Prefectural Government: 1 patents #18 of 63Top 30%
📍 Koganei, MD: #1 of 1 inventorsTop 100%
Overall (All Time): #260,147 of 4,157,543Top 7%
18
Patents All Time

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDate
6642355 Endothelin-antagonizing peptide Takeo Tanaka, Yoshikazu Morishita, Mika Makino, Shigeru Chiba, Isao Kawamoto +11 more 2003-11-04
6593304 RECOMBINANT DNA COMPRISING DNA CODING FOR MYOSIN HEAVY CHAIN SM1 ISO-FORM PROTEIN INSERTED INTO VECTOR DNA MICROORGANISM CARRYING THE RECOMBINANT DNA, AND AN AGENT FOR TREATMENT OF ARTERIOSCLEROSIS COMPRISING THE RECOMBINANT DNA Kazuhide Hasegawa, Emi Arakawa, Shoji Oda, Katsuhito Takahashi, Michihiro Sugahara +1 more 2003-07-15
6489331 Remedies for diabetes Junichi Shimada, Yoshihisa Ohta, Kotaro Takasaki, Miho Suda, Hideaki Kusaka +2 more 2002-12-03
6194195 Strains of streptomyces producing endothelin antagonistic peptides Takeo Tanaka, Yoshikazu Morishita, Mika Makino, Shigeru Chiba, Isao Kawamoto +11 more 2001-02-27
5874592 Physiologically active substance EI-2128-1 Takeo Tanaka, Fumito Koizumi, Tsutomu Agatsuma, Hidemasa Kondo, Yutaka Saitoh +1 more 1999-02-23
5804599 Interleukin-1 production inhibiting compound Takeo Tanaka, Eiji Tsukuda, Keiko Ochiai, Katsuhiko Ando, Hidemasa Kondo +4 more 1998-09-08
5756494 Protein kinase inhibitors for treatment of neurological disorders Michael E. Lewis, James C. Kauer, Nicola Neff, Jill Roberts-Lewis, Chikara Murakata +4 more 1998-05-26
5741808 Protein kinase inhibitors for treatmen of neurological disorders Michael E. Lewis, James C. Kauer, Nicola Neff, Jill Roberts-Lewis, Chikara Murakata +4 more 1998-04-21
5686485 Physiologically active EI-1941 compounds Takeo Tanaka, Hidemasa Kondo, Fumito Koizumi, Hiroki Ishiguro, Mayumi Yoshida +1 more 1997-11-11
5639860 Endothelin-antagonizing peptide Takeo Tanaka, Yoshikazu Morishita, Mika Makino, Shigeru Chiba, Isao Kawamoto +11 more 1997-06-17
5621101 Protein kinase inhibitors for treatment of neurological disorders Michael E. Lewis, James C. Kauer, Nicola Neff, Jill Roberts-Lewis, Chikara Murakata +4 more 1997-04-15
5621100 K-252a derivatives for treatment of neurological disorders Michael E. Lewis, James C. Kauer, Nicola Neff, Jill Roberts-Lewis, Chikara Murakata +4 more 1997-04-15
5461146 Selected protein kinase inhibitors for the treatment of neurological disorders Michael E. Lewis, James C. Kauer, Nicola Neff, Jill Roberts-Lewis, Chikara Murakata +2 more 1995-10-24
5132112 HS-142-1 compounds Yoshikazu Morishita, Mitsuru Takahashi, Koji Yamada, Tomoyuki Sano, Isao Kawamoto +4 more 1992-07-21
5081264 Bioxanthracene derivatives Shinichiro Toki, Mika Nozawa, Mayumi Yoshida, Hiroshi Sano, Katsuhiko Ando +3 more 1992-01-14
4692310 Substance K-259-2 and a process for producing the same Hiroshi Kase, Isao Kawamoto, Kozo Asano, Kunikatsu Shirahata, Tohru Yasuzawa +1 more 1987-09-08
4555402 Physiologically active substance K-252, process for producing same and pharmaceutical composition containing same Kazuyuki Iwahashi, Takao Iida, Noriaki Hirayama, Kozo Asano, Katsuichi Shuto +3 more 1985-11-26
4438197 Compound DC-38-V and process for production thereof Fusao Tomita, Kunikatsu Shirahata, Keiichi Takahashi, Hirofumi Nakano, Tomoyasu Sato +2 more 1984-03-20